​

Neuronetics (STIM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Neuronetics Revenue Highlights

Latest Revenue (Y)

$74.89M

Latest Revenue (Q)

$16.45M

Main Segment (Y)

Medical Device Segment

Neuronetics Revenue by Period

Neuronetics Revenue by Year

DateRevenueChange
2024-12-31$74.89M4.96%
2023-12-31$71.35M9.42%
2022-12-31$65.21M17.89%
2021-12-31$55.31M12.32%
2020-12-31$49.24M-21.41%
2019-12-31$62.66M18.72%
2018-12-31$52.78M30.53%
2017-12-31$40.43M18.13%
2016-12-31$34.23M-

Neuronetics generated $74.89M in revenue during NA 2024, up 4.96% compared to the previous quarter, and up 119.53% compared to the same period a year ago.

Neuronetics Revenue by Quarter

DateRevenueChange
2024-06-30$16.45M-5.55%
2024-03-31$17.42M-14.26%
2023-12-31$20.31M13.59%
2023-09-30$17.88M1.56%
2023-06-30$17.61M13.32%
2023-03-31$15.54M-14.61%
2022-12-31$18.20M10.30%
2022-09-30$16.50M1.03%
2022-06-30$16.33M15.15%
2022-03-31$14.18M-5.60%
2021-12-31$15.02M8.86%
2021-09-30$13.80M-2.84%
2021-06-30$14.20M15.58%
2021-03-31$12.29M-21.12%
2020-12-31$15.58M25.15%
2020-09-30$12.45M27.79%
2020-06-30$9.74M-15.12%
2020-03-31$11.48M-33.88%
2019-12-31$17.36M8.47%
2019-09-30$16.00M-3.45%
2019-06-30$16.57M30.20%
2019-03-31$12.73M-18.59%
2018-12-31$15.63M13.82%
2018-09-30$13.74M3.66%
2018-06-30$13.25M30.54%
2018-03-31$10.15M-16.15%
2017-12-31$12.11M15.41%
2017-09-30$10.49M1.78%
2017-06-30$10.31M36.97%
2017-03-31$7.53M-

Neuronetics generated $16.45M in revenue during Q2 2024, up -5.55% compared to the previous quarter, and up 105.86% compared to the same period a year ago.

Neuronetics Revenue Breakdown

Neuronetics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Medical Device Segment$74.89M

Neuronetics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Medical Device Segment (100.00%).

Neuronetics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FONRFONAR$102.88B$2.02M
SHCSotera Health$1.10B$285.47M
BNRBurning Rock Biotech$537.43M$125.62M
STIMNeuronetics$74.89M$16.45M
BDSXBiodesix$71.32M$18.15M
XGNExagen$55.64M$15.06M
ENZEnzo Biochem$31.91M$7.33M
DRIODarioHealth$27.04M$6.25M
SERASera Prognostics$77.00K$24.00K

STIM Revenue FAQ

What is Neuronetics’s yearly revenue?

Neuronetics's yearly revenue for 2024 was $74.89M, representing an increase of 4.96% compared to 2023. The company's yearly revenue for 2023 was $71.35M, representing an increase of 9.42% compared to 2022. STIM's yearly revenue for 2022 was $65.21M, representing an increase of 17.89% compared to 2021.

What is Neuronetics’s quarterly revenue?

Neuronetics's quarterly revenue for Q2 2024 was $16.45M, a -5.55% decrease from the previous quarter (Q1 2024), and a -6.59% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $17.42M, a -14.26% decrease from the previous quarter (Q4 2023), and a 12.08% increase year-over-year (Q1 2023). STIM's quarterly revenue for Q4 2023 was $20.31M, a 13.59% increase from the previous quarter (Q3 2023), and a 11.63% increase year-over-year (Q4 2022).

What is Neuronetics’s revenue growth rate?

Neuronetics's revenue growth rate for the last 3 years (2022-2024) was 14.85%, and for the last 5 years (2020-2024) was 52.08%.

What are Neuronetics’s revenue streams?

Neuronetics's revenue streams in c 24 are Medical Device Segment

What is Neuronetics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Neuronetics was Medical Device Segment. This segment made a revenue of $74.89M, representing 100.00% of the company's total revenue.